Literature DB >> 22496925

Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growth.

Jacob E Koskimaki1, Elena V Rosca, Corban G Rivera, Esak Lee, William Chen, Niranjan B Pandey, Aleksander S Popel.   

Abstract

Angiogenesis is the formation of neovasculature from preexisting microvessels. Several endogenous proteins regulate the balance of vessel formation and regression in the body including pigment epithelium-derived factor (PEDF), which has been shown to be antiangiogenic and to suppress tumor growth. Using sequence homology and bioinformatics, we previously identified several peptide sequences homologous to an active region of PEDF existing in multiple proteins in the human proteome. These short 11-mer peptides are found in a DEAH box helicase protein, CKIP-1 and caspase 10, and show similar activity in altering endothelial cell adhesion, migration and inducing apoptosis.We tested the peptide derived from DEAH box helicase protein in a triple-negative MDA-MB-231 breast orthotopic xenograft model in severe combined immunodeficient mice and show significant tumor suppression.

Entities:  

Year:  2012        PMID: 22496925      PMCID: PMC3323930          DOI: 10.1593/tlo.11244

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  31 in total

Review 1.  JNK: a key modulator of intracellular signaling.

Authors:  S Vlahopoulos; V C Zoumpourlis
Journal:  Biochemistry (Mosc)       Date:  2004-08       Impact factor: 2.487

Review 2.  Development of new targeted therapies for breast cancer.

Authors:  Danielle M Doyle; Kathy D Miller
Journal:  Cancer Treat Res       Date:  2008

3.  A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells.

Authors:  Emmanouil D Karagiannis; Aleksander S Popel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

Review 4.  Antiangiogenic therapies in early-stage breast cancer.

Authors:  Christina Derleth; Ingrid A Mayer
Journal:  Clin Breast Cancer       Date:  2010       Impact factor: 3.225

Review 5.  Structure-function relationships of PEDF.

Authors:  T Kawaguchi; S-I Yamagishi; M Sata
Journal:  Curr Mol Med       Date:  2010-04       Impact factor: 2.222

Review 6.  Triple negative breast cancer: unmet medical needs.

Authors:  Sumanta Kumar Pal; Barrett H Childs; Mark Pegram
Journal:  Breast Cancer Res Treat       Date:  2010-12-15       Impact factor: 4.872

Review 7.  The neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights into phylogeny, function, and signaling.

Authors:  Joyce Tombran-Tink
Journal:  Front Biosci       Date:  2005-09-01

Review 8.  Angiogenesis: an organizing principle for drug discovery?

Authors:  Judah Folkman
Journal:  Nat Rev Drug Discov       Date:  2007-04       Impact factor: 84.694

Review 9.  Mechanisms of disease: angiogenesis and the management of breast cancer.

Authors:  Susana Banerjee; Mitch Dowsett; Alan Ashworth; Lesley-Ann Martin
Journal:  Nat Clin Pract Oncol       Date:  2007-09

10.  The anti-angiogenic peptide anginex greatly enhances galectin-1 binding affinity for glycoproteins.

Authors:  Emma Salomonsson; Victor L Thijssen; Arjan W Griffioen; Ulf J Nilsson; Hakon Leffler
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

View more
  9 in total

1.  Effects of pigment epithelium derived factor (PEDF) on malignant peripheral nerve sheath tumours (MPNSTs).

Authors:  Maria Demestre; Menderes Yusuf Terzi; Victor Mautner; Peter Vajkoczy; Andreas Kurtz; Ana Luisa Piña
Journal:  J Neurooncol       Date:  2013-12       Impact factor: 4.130

2.  Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization.

Authors:  Jayoung Kim; Raquel Lima E Silva; Ron B Shmueli; Adam C Mirando; Stephany Y Tzeng; Niranjan B Pandey; Elana Ben-Akiva; Aleksander S Popel; Peter A Campochiaro; Jordan J Green
Journal:  Acta Biomater       Date:  2019-07-30       Impact factor: 8.947

Review 3.  Computational systems biology approaches to anti-angiogenic cancer therapeutics.

Authors:  Stacey D Finley; Liang-Hui Chu; Aleksander S Popel
Journal:  Drug Discov Today       Date:  2014-10-05       Impact factor: 7.851

4.  Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide.

Authors:  Ron B Shmueli; Masayuki Ohnaka; Akiko Miki; Niranjan B Pandey; Raquel Lima e Silva; Jacob E Koskimaki; Jayoung Kim; Aleksander S Popel; Peter A Campochiaro; Jordan J Green
Journal:  Biomaterials       Date:  2013-07-10       Impact factor: 12.479

5.  Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice.

Authors:  Stacey D Finley; Manjima Dhar; Aleksander S Popel
Journal:  Front Oncol       Date:  2013-07-30       Impact factor: 6.244

6.  Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis.

Authors:  Kerri-Ann Norton; Aleksander S Popel
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

7.  PLEKHO1 knockdown inhibits RCC cell viability in vitro and in vivo, potentially by the Hippo and MAPK/JNK pathways.

Authors:  Zi Yu; Qiang Li; Gejun Zhang; Chengcheng Lv; Qingzhuo Dong; Cheng Fu; Chuize Kong; Yu Zeng
Journal:  Int J Oncol       Date:  2019-05-30       Impact factor: 5.650

Review 8.  A systems biology view of blood vessel growth and remodelling.

Authors:  Elizabeth A Logsdon; Stacey D Finley; Aleksander S Popel; Feilim Mac Gabhann
Journal:  J Cell Mol Med       Date:  2013-11-17       Impact factor: 5.310

9.  Prediction of high anti-angiogenic activity peptides in silico using a generalized linear model and feature selection.

Authors:  Jose Liñares Blanco; Ana B Porto-Pazos; Alejandro Pazos; Carlos Fernandez-Lozano
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.